PhRMA has long criticized medicines insurance schemes premised on cost-effectiveness and reference pricing such as the Pharmaceutical Benefits Scheme (PBS) in Australia and PHARMAC in New Zealand. The PhRMA submission to the USTR on the TTPA specifically targets alleged ‘market access barriers... inadequate consultative mechanisms and transparency concerns in countries like New Zealand’6. But t...

The Trans Pacific Partnership Agreement (TPPA) is a regional trade agreement currently being negotiated by 11 Pacific Rim countries, excluding China. While the negotiations are being conducted under a veil of secrecy, substantive leaks over the past 4 years have revealed a broad view of the proposed contents. As it stands the TPPA poses serious risks to global public health, particularly chroni...

Ashley Schram MSW, is a PhD candidate in Population Health at the University of Ottawa, Ottawa, Ontario. Ronald Labonte is Canada Research Chair in Globalization and Health Equity, Institute of Population Health, and Professor, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario. Kapil Khatter is a family physician, a Fellow of the Broadbent Institute, and a...

BACKGROUND In early October 2015, 12 nations signed the Trans-Pacific Partnership Agreement (TPPA), promoted as a model '21(st) century' trade and investment agreement that other countries would eventually join. There are growing concerns amongst the public health community about the potential health implications of such WTO+ trade and investment agreements, but little existing knowledge on the...

In 2020, the Regional Comprehensive Economic Partnership (RCEP) agreement was signed. The RCEP Agreement is largest regional trade in world terms of total GDP. Asia-Pacific region, there are various and bilateral agreements that lead to not only overlapping substantive provisions, but also dispute settlement for a. It important review procedural aspects as means enforce rules commitments its me...